Cancer News and Research

Latest Cancer News and Research

Techne acquires Tocris Holdings

Techne Corporation announced today that it has acquired 100% ownership of Tocris Holdings Limited and subsidiaries, a leading supplier of reagents for non-clinical life science research.

3 May 2011

Lopinavir can combat HPV-related cervical cancer

A widely used HIV drug could be used to prevent cervical cancer caused by infection with the human papilloma virus, say scientists.

3 May 2011

Study finds disparities in male, female patients for heart disease treatment at U.S. hospitals

A study released today by HealthGrades, the nation's leading, independent source of physician information and hospital quality ratings, found notable disparities in the treatment and outcomes of male and female patients at U.S. hospitals.

3 May 2011

CTI to re-submit pixantrone NDA to FDA's Office of New Drugs for re-review

Cell Therapeutics, today announced that the Office of New Drugs of the U.S. Food and Drug Administration after carefully reviewing the materials CTI submitted in support of its appeal, the reviews of the New Drug Application for pixantrone prepared by the FDA staff, the transcript of the March 22, 2010 Oncology Drugs Advisory Committee meeting and consulting with the Center for Drug Evaluation and Research's Deputy Director of Clinical Science and the Office of Biostatistics, concluded that accelerated approval of pixantrone NDA 022481 may not necessarily be out of reach based on a single controlled clinical trial, provided two key matters can be satisfactorily resolved.

3 May 2011

MRI can effectively determine patients with endometrial and cervical cancers

MRI can determine if a patient has endometrial versus cervical cancer even when a biopsy can't make that distinction, according to a new study. Determining the primary site of a tumor helps determine appropriate cancer treatment.

3 May 2011

U.Va, Coulter Foundation partner for translational research in biomedical engineering

The University of Virginia and the Wallace H. Coulter Foundation have teamed to create a $20 million endowment to foster research collaboration between biomedical engineers and clinicians, with the goal of developing new technologies to improve patient care and human health.

3 May 2011

Tecnologie Avanzate, Naviscan sign deal to distribute PET scanner in Italy

Naviscan, Inc., the leader in 3D Molecular Breast Imaging, has entered into a distribution agreement with Tecnologie Avanzate s.r.l. to market and service Naviscan's high-resolution organ-specific PET scanner in Italy.

3 May 2011

JPO issues patent to Silence Therapeutics' RNAi technology

Silence Therapeutics plc announces the issuance of patent 4,705,370, titled "Further Novel Forms of Interfering RNA Molecules," by the Japanese Patent Office.

3 May 2011

Eurotrans-Bio awards 1.1 million grant to MDxHealth, NovioGendix for bladder cancer program

MDxHealth SA, a leading molecular diagnostics company in the field of personalized cancer treatment, today announced that together with partner NovioGendix B.V., a molecular diagnostics company spun out from Radboud University Nijmegen Medical Centre, the Netherlands, has received a USD 1.1 million grant from Eurotrans-Bio to progress its bladder cancer program.

3 May 2011

Ipsen first quarter sales increase 6.1% to €285.8 million

Ipsen reported today its sales for the first quarter 2011.

3 May 2011

Study shows how secondhand smoke may increase vulnerability to nicotine addiction

Exposure to secondhand smoke, such as a person can get by riding in an enclosed car while someone else smokes, has a direct, measurable impact on the brain-and the effect is similar to what happens in the brain of the person doing the smoking.

3 May 2011

Guided Therapeutics launches LuViva Advanced Cervical Scan

Guided Therapeutics, Inc., unveiled the new name and new industrial design for its non-invasive and painless test for the early detection of cervical precancer.

3 May 2011

FDA approves new targeted therapy to treat men with advanced prostate cancer

The Food and Drug Administration on Thursday approved abiraterone, a new targeted therapy in the class of androgen receptor blockers.

3 May 2011

McMaster receives new Canadian Cancer Society grants for groundbreaking research

Three cancer studies led by Hamilton researchers are among 52 new research projects worth close to $22 million announced by the Canadian Cancer Society.

3 May 2011

Scientists discover new gene underlying angle-closure glaucoma

Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.

3 May 2011

Statins can help reduce lung damage in severe abdominal sepsis

Statins may be best known for their ability to reduce cholesterol, but a research report appearing in the May 2011 issue of the Journal of Leukocyte Biology shows that these same drugs could also play a crucial role in the reduction of lung damage resulting from severe abdominal sepsis and infection.

3 May 2011